Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn 0 10.01.2025 21:26 Financial Times Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
